Nilotinib-Associated Destructive Thyroiditis

Protein tyrosine kinase inhibitors are currently an important drug class in the treatment of leukemia. They represent targeted cancer therapy and have become the treatment of choice in chronic myeloid leukemia. Tyrosine kinases are enzymes expressed in multiple tissues and are involved in several si...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakerywala, Suhalia, Schwarcz, Monica D., Goldberg, Michael D., Valiquette, Guy, Weiss, Irene A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439480/
https://www.ncbi.nlm.nih.gov/pubmed/26064704
http://dx.doi.org/10.1155/2015/736092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439480/
https://www.ncbi.nlm.nih.gov/pubmed/26064704
http://dx.doi.org/10.1155/2015/736092

Ejemplares similares